At the 2023 Uromigos Live & Unplugged event, Tanya Dorff, MD, City of Hope, and Neeraj Agarwal, MD, University of Utah, share how crucial it is for metastatic prostate cancer patients around the world to undergo germline or tumor somatic gene testing, even thought there is not yet a targeted therapy available for these patients in the hormone-sensitive setting.

свернуть